EDITORIAL
Published on 18 Sep 2023
Editorial: Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
doi 10.3389/fendo.2023.1287807
- 1,205 views
- 1 citation
- Frontiers in Endocrinology
- Diabetes: Molecular Mechanisms
- Research Topics
- Pharmacogenomics and Pharmacomicrobiomics in Type 2 Diabetes Mellitus (T2DM)
Pharmacogenomics and Pharmacomicrobiomics in Type 2 Diabetes Mellitus (T2DM)
13k
Total downloads
38k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 23 Aug 2023
Gene–diet interaction analysis using novel weighted food scores discovers the adipocytokine signaling pathway associated with the development of type 2 diabetes
doi 10.3389/fendo.2023.1165744
- 1,894 views
- 1 citation
REVIEW
Published on 09 May 2023
Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus
doi 10.3389/fendo.2023.1114424
- 10,520 views
- 45 citations
REVIEW
Published on 23 Mar 2023
Pharmacomicrobiomics and type 2 diabetes mellitus: A novel perspective towards possible treatment
doi 10.3389/fendo.2023.1149256
- 2,592 views
- 6 citations
CLINICAL TRIAL
Published on 17 Feb 2023
Probiotics intervention in preventing conversion of impaired glucose tolerance to diabetes: The PPDP follow-on study
doi 10.3389/fendo.2023.1113611
- 2,221 views
- 1 citation
ORIGINAL RESEARCH
Published on 26 Jan 2023
Sodium glucose co-transporter 2 (SGLT2) inhibition via dapagliflozin improves diabetic kidney disease (DKD) over time associatied with increasing effect on the gut microbiota in db/db mice
doi 10.3389/fendo.2023.1026040
- 3,574 views
- 14 citations
ORIGINAL RESEARCH
Published on 14 Nov 2022
Tandem mass tag-based proteomic profiling revealed potential therapeutic targets and mechanisms of liraglutide for the treatment of impaired glucose tolerance
doi 10.3389/fendo.2022.1031019
- 1,309 views
ORIGINAL RESEARCH
Published on 16 Aug 2022
Effects of PPARD gene variants on the therapeutic responses to exenatide in chinese patients with type 2 diabetes mellitus
doi 10.3389/fendo.2022.949990
- 2,069 views
- 6 citations
PERSPECTIVE
Published on 07 Jul 2022
Is Intestinal Dysbiosis-Associated With Immunosuppressive Therapy a Key Factor in the Pathophysiology of Post-Transplant Diabetes Mellitus?
doi 10.3389/fendo.2022.898878
- 2,575 views
- 5 citations
REVIEW
Published on 04 May 2022
Pharmacomicrobiomics in Western Medicine and Traditional Chinese Medicine in Type 2 Diabetes
doi 10.3389/fendo.2022.857090
- 4,301 views
- 10 citations
Published in
Frontiers in Endocrinology
- Diabetes: Molecular Mechanisms
- Systems Endocrinology
Impact
- 38kTopic views
- 23kArticle views
- 13kArticle downloads